Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Randomised Study of Docosahexaenoic Acid (DHA) in Metastatic Breast Cancer (DHALYA)

This study has been terminated.
(Judicial liquidation of the society providing dietary supplementation.)
ICO Paul Papin
Information provided by (Responsible Party):
University Hospital, Tours Identifier:
First received: February 27, 2012
Last updated: July 28, 2015
Last verified: July 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2014
  Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)